How to Buy Tarsus Pharmaceuticals Stock
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions.
Tarsus Pharmaceuticals stock last closed at $72.70, up 1.69% from the previous day, and has increased 28.54% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Tarsus Pharmaceuticals stock is currently +50.83% from its 52-week low of $48.20, and -14.72% from its 52-week high of $85.25.
At the moment, there are 43.88M TARS shares outstanding. The market value of TARS is $3.19B. In the last 24 hours, 570,000 TARS shares were traded.
How to Buy Tarsus Pharmaceuticals Stock
Wondering how to invest in Tarsus Pharmaceuticals stock? Here's how.
- Choose where to buy Tarsus Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Tarsus Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Choose your payment method and add your information.
- Research Tarsus Pharmaceuticals stock: The Tarsus Pharmaceuticals ticker symbol is TARS. Is Tarsus Pharmaceuticals stock a good investment? Should you buy shares of TARS? How do TARS's underlying business fundamentals look? Do top analysts think Tarsus Pharmaceuticals is a good buy? Why has TARS's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if TARS is a good stock to buy).
- Make your TARS buy order: Decide if you will purchase TARS shares at the current market price or use a limit order to purchase TARS stock at a particular price.
- Keep tabs on your TARS investment: Create a watchlist to key updates about your new investment in Tarsus Pharmaceuticals shares.
Step 1: Choose where to buy Tarsus Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy TARS shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal info so you are able to buy TARS stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on the best stock investing app, your next step is to transfer the money for your investment:
Check out the video below to see the process of depositing money into your new investment account.
Step 4: Research Tarsus Pharmaceuticals stock
After you have figured out the best place to buy Tarsus Pharmaceuticals stock, it's very important to analyze their stock before you buy, so you truly wrap your head around the risk as well as the opportunity.
Tarsus Pharmaceuticals shares quick numbers
TARS Fundamentals
WallStreetZen was built to help average investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on TARS's stock page.
Is TARS stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge TARS's true value.
Using relative valuations measures:
- TARS may be overvalued based on its P/B ratio of 9.2x, relative to Biotechnology industry P/B ratio of 5.61x
You can access more valuation analysis on TARS's stock here.
TARS Financial Overview
Pros:
- There are more short-term assets than long-term liabilities on the TARS balance sheet.
- TARS profit margin has gone up from -31.1% to -7.7% in the past year.
- TARS's operating cash flow of $74.16M allows it to safely service it's debt of $72.76M.
- There are more short-term assets than short-term liabilities on the TARS balance sheet.
Cons:
- TARS has a relatively high debt to equity ratio of 0.76.
- TARS earnings of -$30.58M is not sufficient to cover its interest payments.
- Total TARS debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy Tarsus Pharmaceuticals stock, according to Wall Street analysts?
Out of 5 Wall Street analysts who track TARS, the consensus analyst rating on TARS is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Tarsus Pharmaceuticals stock forecast page.
TARS Technicals
How are TARS Revenues/Earnings doing?
Last year, TARS revenue was $606.33M. In the past 5 year, TARS's revenue has grown by 61.35% per year. This was faster than the Biotechnology industry average of 23.17%.
Dive into TARS's earnings and revenue performance here.
Who is buying/selling TARS?
Over the past year, insiders at TARS have sold more shares than they have bought.
Bobak R. Azamian, PresidentCEO and Board Chair of TARS, was the latest TARS insider to sell. They sold $280,601.68 worth of TARS shares on Jun 17, 2026.
Research more about who owns TARS shares here.
Does TARS provide a stable income stream?
No, Tarsus Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about TARS
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your TARS buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Click the Open button and eToro will execute the order.
If you need additional help buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your TARS investment
Now that you own some TARS stock, you'll want to stay up-to-date on your new company.
Make a watchlist to keep track of your TARS stock.
TARS Feed
How to Buy Stock in Tarsus Pharmaceuticals
To reiterate, here are the 6 steps to buy Tarsus Pharmaceuticals stock:
- Choose where to buy Tarsus Pharmaceuticals stock
- Create a brokerage account
- Fund your brokerage account
- Research Tarsus Pharmaceuticals stock
- Make your TARS buy order
- Keep tabs on your TARS investment
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Tarsus Pharmaceuticals, create your watchlist below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.